Compare COYA & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COYA | MCN |
|---|---|---|
| Founded | 2020 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 125.6M |
| IPO Year | 2022 | N/A |
| Metric | COYA | MCN |
|---|---|---|
| Price | $4.82 | $6.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | ★ 302.7K | 52.9K |
| Earning Date | 03-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,987,706.00 | N/A |
| Revenue This Year | $70.00 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.94 | $6.69 |
| 52 Week High | $8.29 | $8.60 |
| Indicator | COYA | MCN |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 52.48 |
| Support Level | $4.41 | $5.95 |
| Resistance Level | $4.97 | $6.09 |
| Average True Range (ATR) | 0.29 | 0.06 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 43.84 | 72.09 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.